We could not find any results for:
Make sure your spelling is correct or try broadening your search.
We are Viatris. A new kind of global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines advance sustainable operations develop innovative solutions and leverage our collective expertise to connect more people to more products and s... We are Viatris. A new kind of global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines advance sustainable operations develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway. Formed in November 2020 we bring together scientific manufacturing and distribution expertise with proven regulatory medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. At Viatris our portfolio comprises more than 1400 approved molecules across a wide range of therapeutic areas spanning both non-communicable and infectious diseases including globally recognized brands complex generic and branded medicines and a growing portfolio of biosimilars. Show more
Viatris to Participate in the BofA Securities 2024 Health Care Conference PR Newswire PITTSBURGH, May 2, 2024 PITTSBURGH, May 2, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global...
Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health PR Newswire PITTSBURGH and LONDON, May 1, 2024 PITTSBURGH and LONDON, May 1...
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024 PR Newswire PITTSBURGH, April 16, 2024 PITTSBURGH, April 16, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its...
Viatris Appoints Corinne Le Goff as Chief Commercial Officer PR Newswire PITTSBURGH, April 15, 2024 PITTSBURGH, April 15, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare...
Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada Canada NewsWire ETOBICOKE, ON, April 15, 2024 New generic Multiple Sclerosis treatment...
Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States PR Newswire PITTSBURGH, April 1, 2024 PITTSBURGH, April 1, 2024 /PRNewswire/ -- Viatris Inc...
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline PR Newswire PITTSBURGH, March 27, 2024 PITTSBURGH...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.44 | 3.84951881015 | 11.43 | 11.865 | 11.4 | 9594966 | 11.61136904 | CS |
4 | 0.15 | 1.27986348123 | 11.72 | 11.9 | 11.05 | 6834248 | 11.50908633 | CS |
12 | 0.36 | 3.12771503041 | 11.51 | 13.6175 | 11.05 | 9168038 | 12.15475622 | CS |
26 | 2.8 | 30.8710033076 | 9.07 | 13.6175 | 8.95 | 9196399 | 11.31911748 | CS |
52 | 2.71 | 29.5851528384 | 9.16 | 13.6175 | 8.74 | 9152922 | 10.60337026 | CS |
156 | -1.43 | -10.7518796992 | 13.3 | 16.29 | 8.42 | 9754948 | 11.4191828 | CS |
260 | -4.59 | -27.8857837181 | 16.46 | 18.86 | 8.42 | 10086424 | 12.16068557 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions